×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Oncternal Therapeutics to Provide Business Update and Report First Quarter 2024 Financial Results
GlobeNewswire
SAN DIEGO, May 02, 2024 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused...
1 day ago
Oncternal Therapeutics (ONCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
Yahoo News Singapore
Oncternal Therapeutics (ONCT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.
2 days ago
Oncternal Therapeutics reports patient death in CAR-T dose-escalation study
Fierce Biotech
Oncternal Therapeutics has reported the death of a patient in a clinical trial following an elevated dose of its autologous CAR-T therapy...
4 months ago
Oncternal Therapeutics reports inducement award under Nasdaq listing rule - TipRanks.com
Tipranks
Oncternal Therapeutics announced the approval of an inducement award to one new employee, Anne C. Hansen, who is joining Oncternal as Senior...
3 days ago
Oncternal Therapeutics (NASDAQ:ONCT) Coverage Initiated at StockNews.com
Defense World
Read Oncternal Therapeutics (NASDAQ:ONCT) Coverage Initiated at StockNews.com at Defense World.
1 day ago
Oncternal Therapeutics (ONCT) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Zacks Investment Research
Oncternal Therapeutics (ONCT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming...
1 week ago
Can Oncternal Therapeutics (NASDAQ:ONCT) Afford To Invest In Growth?
Simply Wall St
You can calculate a company's cash runway by dividing the amount of cash it has by the rate at which it is spending that cash. In September 2023...
2 months ago
Oncternal Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financial Results
Yahoo Finance
SAN DIEGO, March 07, 2024 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on...
1 month ago
Oncternal Therapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line
Yahoo Finance
Oncternal Therapeutics ( NASDAQ:ONCT ) Full Year 2023 Results Key Financial Results Net loss: US$39.5m (loss narrowed...
1 month ago
Oncternal Therapeutics Enrolls Patients into the Third Dosing Cohort of its Phase 1/2 Study of ONCT-534 for the ...
Yahoo Finance
SAN DIEGO, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused...
3 months ago